← Open Payments lookup

VICKI FITZGERALD: Open Payments

NPI 1154563005 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,013 in 106 payments from 19 companies in 2025. Trend: 2023 $1,588 · 2024 $1,520 · 2025 $2,013

Food & beverage: $2,013
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$291
GENZYME CORPORATION11$230
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$212
ABBVIE INC.20$200
Aimmune Therapeutics, Inc.10$200
Ardelyx, Inc.9$166
Phathom Pharmaceuticals, Inc.3$140
Takeda Pharmaceuticals U.S.A., Inc.6$96
QOL Medical, LLC4$94
Ipsen Biopharmaceuticals, Inc4$79

Products named: DUPIXENT, REZDIFFRA, XIFAXAN, ZENPEP, IBSRELA, VOQUEZNA, ENTYVIO, Sucraid.

Industry payments across MS — which companies pay providers there.